S428-0227 Screening compound: N~1~-(4-methylbenzyl)-3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)tetrahydro-1(2H)-pyridinecarboxamide

S428-0227 Screening compound: N~1~-(4-methylbenzyl)-3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)tetrahydro-1(2H)-pyridinecarboxamide
S428-0227 Screening compound: N~1~-(4-methylbenzyl)-3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)tetrahydro-1(2H)-pyridinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S428-0227
N~1~-(4-methylbenzyl)-3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)tetrahydro-1(2H)-pyridinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S428-0227

Molecular Formula

C21H28N4O3 (C21 H28 N4 O3)

Compound Name

N~1~-(4-methylbenzyl)-3-(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)tetrahydro-1(2H)-pyridinecarboxamide

IUPAC name

N-[(4-methylphenyl)methyl]-3-[3-(oxan-4-yl)-124-oxadiazol-5-yl]piperidine-1-carboxamide

SMILES

Cc1ccc(CNC(N(CCC2)CC2c2nc(C3CCOCC3)no2)=O)cc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

384.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.300

Distribution Coefficient, logD

3.300

Water Solubility, LogSw

-3.22

Polar Surface Area

66.470

Acid Dissociation Constant (pKa)

14.42

Base Dissociation Constant (pKb)

-0.11

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

57.14

S428-0227 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • Ion Channels
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S428-0227 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S428-0227?
Check Price and Availability of S428-0227, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S428-0227 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S428-0227
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S428-0227
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S428-0227 available by request